The Changing Landscape of the Prostate Cancer Therapeutics Market
Given its position as a leading contributor to male cancer mortality, this malignancy has warranted substantial research allocation, generating a sophisticated commercial ecosystem distinguished by translational research advances and therapeutic portfolio diversification
